newsfilter
← Latest News
PR Newswire·

Valion Bio to Report First Quarter 2026 Financial Results on May 14, 2026

Valion Bio, Inc. (formerly Tivic Health Systems, Inc.) (Nasdaq: VBIO), a clinical-stage immunotherapeutics company developing Entolimod™ for Acute...